Close
Help





JOURNAL

Gene Expression to Genetical Genomics

Interleukin 1 Beta Gene Polymorphism in Schizophrenia and Psychotic Depression

Submit a Paper


Gene Expression to Genetical Genomics 2010:3 7-12

Original Research

Published on 25 Oct 2010

DOI: 10.4137/GGG.S5754


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Gene Expression to Genetical Genomics

Abstract

The proinflammatory interleukin 1 beta serum level is elevated in schizophrenic patients. Like other proinflammatory cytokine, it is in part dependant on genetic expression, so it may represent a candidate susceptibility gene for schizophrenia. It plays a crucial role in development of the Central Nervous System (CNS) and may, hence, influence brain morphology in schizophrenia. The theory that psychotic depression is a distinct syndrome that has to be differentiated from non psychotic depression, is supported by literature showing substantial difference between them in clinical manifestations, biological laboratory measures, family transmission, course, response to treatment and prognosis. Our work attempts to assess Interleukin 1 beta gene polymorphism in psychotic depression and schizophrenia, which may potentially represent a genetic differentiating biological marker, taking in consideration the diagnostic difficulty that rises when evaluating those two disorders, though of different management and outcome, but largely similar in terms of presenting symptoms.



Downloads

PDF  (537.70 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services